Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Capital Expenditures (2022 - 2025)

GE HealthCare Technologies' Capital Expenditures history spans 4 years, with the latest figure at $53.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Capital Expenditures rose 133.97% year-over-year to $53.0 million, compared with a TTM value of $164.0 million through Dec 2025, up 14.69%, and an annual FY2025 reading of $164.0 million, up 14.69% over the prior year.
  • Capital Expenditures for Q4 2025 was $53.0 million at GE HealthCare Technologies, up from $21.0 million in the prior quarter.
  • The five-year high for Capital Expenditures was $223.0 million in Q3 2024, with the low at -$156.0 million in Q4 2024.
  • Average Capital Expenditures over 4 years is $47.3 million, with a median of $56.0 million recorded in 2022.
  • Year-over-year, Capital Expenditures soared 2130.0% in 2024 and then tumbled 369.57% in 2025.
  • Tracing GEHC's Capital Expenditures over 4 years: stood at $77.0 million in 2022, then dropped by 22.08% to $60.0 million in 2023, then plummeted by 360.0% to -$156.0 million in 2024, then surged by 133.97% to $53.0 million in 2025.
  • Per Business Quant, the three most recent readings for GEHC's Capital Expenditures are $53.0 million (Q4 2025), $21.0 million (Q3 2025), and -$62.0 million (Q2 2025).